Professor of Cancer Biology

Southampton, United Kingdom
18 Jul 2022
End of advertisement period
21 Aug 2022
Contract Type
Full Time

Cancer Sciences

Location:  Southampton General Hospital
Salary:   Competitive: Salary will be commensurate with qualifications and experience (Level 7)
Full Time Permanent
Closing Date:  Sunday 21 August 2022
Interview Date:   To be confirmed
Reference:  1703122CM

The University of Southampton seeks to recruit a new Professor of cancer biology to expand on our existing programmes and track record in this area, ideally in the field of lymphoid malignancy.

Over the last 30 years, our collaborative research teams, based on a single hospital site, have made important contributions to the study of normal and malignant lymphoid biology. Our research has helped transform the understanding and treatment of the most common adult leukaemia, Chronic Lymphocytic Leukaemia (CLL). Our discovery of two distinct CLL subsets has given clinicians and patients a much clearer indication of the likely disease course and has inspired the development of novel therapeutics. In parallel, our observations have driven major advances in lymphoma care, leading to the development and standardisation of effective new antibody treatments and optimal drug regimens (e.g. antibodies that target the CD20 protein). Through our leadership of international clinical trials, we have transformed the standard of care for different lymphoid malignancies (e.g. Hodgkin and Burkitt lymphoma) in the UK and internationally, affecting all stages of patient experience from diagnosis to treatment. 

We now wish to further strengthen this area of our research with additional expertise in the fundamental biology of lymphoid malignancy. We seek an experienced and internationally recognised candidate with outstanding credentials in the field, someone with proven experience who will be attracted to a role in Southampton by our record in B cell biology and cancer immunology/immunotherapy, and our proven capabilities in clinical translation, taking results from the laboratory directly to patients. 

The successful candidate will have a strong international profile in the molecular and cellular biology of cancer and add synergy and/or a new dimension to our research activities. The successful individual will join a passionate team of basic and translational scientists working in close collaboration with clinical colleagues in our Biomedical Campus at Southampton General Hospital, in purpose-built laboratories in the Somers Building and the Centre for Cancer Immunology. Our work is under-pinned by multiple programme and accelerator awards from Cancer Research UK (CRUK), and houses a CRUK Centre, a CRUK/NIHR Experimental Cancer Medicine Centre, and a CRUK Clinical Trials Unit. 

More than 250 researchers, clinicians and associated staff focus on all aspects of cancer research, with particular focus on cancer immunology/immunotherapy, cell biology and engineering antibodies to generate therapeutics. Through close interactions of our researchers with the clinical trials unit, we bring ideas and discoveries made in the laboratory into clinical practice as rapidly as possible and ensure that the mechanisms underlying cancer treatments are understood.

We welcome applications from all candidates with an interest in the role, and those who are committed to helping us create an inclusive work environment. We especially encourage applications from candidates from Black, Asian and Minority Ethnic communities, people who identify as LGBTQ+ and people with disabilities.

For further details about the post you are invited to contact the Head of School, Professor Jonathan Strefford

You should submit your completed online application form at The application deadline will be midnight on the closing date stated above. Please submit details for 3 referees and include your CV and publication list with your application. If you need any assistance, please call Sian Gale (Recruitment Team) on +44 (0) 23 8059 2750, or email Please quote reference 1703122CM on all correspondence.